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Cardiovascular diseases account for the second largest
number of non-communicable disease after mental
illnesses. Coronary heart diseases, hypertension, athero-
sclerosis, congestive heart failure, arrhythmias are
important cardiovascular diseases. Beta blockers, statins,
antiplatelet drugs, anticoagulants, drugs modifying renin
angiotensin systems and many others are being used for
treating these ailments. Still, satisfactory treatment of
these diseases is still elusive. Drug response in influenced
by many environmental factors besides host factor.
Besides the above, genetic factor is also important in
modifying response to cardiovascular drugs. Now there is
reasonable amount of evidence exists that Indian popula-
tion is genetically distinct from other major ethnic groups.
The allele and genotype frequencies of genes encoding
important drug metabolizing enzymes, drug transporters
and receptors of Indian population are different from
Caucasians and Orientals. Studies done in our laboratory
and other Indian laboratories suggested that pharmacoge-
nomics of clopidogrel, warfarin, acenocoumarol, beta
blockers etc. may have clinical significance in treating car-
diovascular diseases of Indian population. There is a need
for multi-institutional and multi-disciplinary approach for
large scale implementation of pharmacogenomics and
personalized medicines in cardiovascular diseases.
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